GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

NCT04601402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Non Small Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Urothelial Carcinoma

Interventions

DRUG: GEN-001
DRUG: Avelumab

Sponsor

Genome & Company

Collaborators

[object Object]
[object Object]